CytomX Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Welcome, everyone, to the 40th Annual JPMorgan Healthcare Conference. My name is Anupam Rama. I'm one of the senior biotech analysts here at JPMorgan. I am joined by Caleb Smith, Malcolm Kuno and Priyanka Grover from the team.
Our next presenting company is CytomX. And presenting on behalf of the company, we have CEO, Sean McCarthy. (Operator Instructions)
With that, Sean, take it away.
Great. Thanks, Anupam, and good afternoon, everyone. I'd like to thank the JPMorgan team for the invitation to present today. It's really a pleasure to be here.
Moving to Slide 2. During my presentation today, I will be making certain forward-looking statements, and I refer you to our regulatory filings.
Slide 3. So our goal at CytomX is to destroy cancer differently, leveraging our unique approach to the discovery and development of targeted biologic therapeutics.
Slide 4. To
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
